Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eltrombopag”

172 trials

Showing 20 of 172 results

Testing effectiveness (Phase 2)Study completedNCT04269889
What this trial is testing

Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag

Who this might be right for
Anemia, Diamond-Blackfan
National Heart, Lung, and Blood Institute (NHLBI) 15
Large-scale testing (Phase 3)Study completedNCT00370331
What this trial is testing

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 197
Testing effectiveness (Phase 2)Ended earlyNCT03948529
What this trial is testing

RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation

Who this might be right for
LeukemiaGraft Failure
University Hospital, Lille 9
Testing effectiveness (Phase 2)UnknownNCT05286164
What this trial is testing

Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART

Who this might be right for
CART TreatmentB Cell Lymphoma
Tel-Aviv Sourasky Medical Center 30
Early research (Phase 1)Study completedNCT02254434
What this trial is testing

A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions

Who this might be right for
Cirrhosis, Liver
GlaxoSmithKline 26
Post-approval studies (Phase 4)UnknownNCT04102033
What this trial is testing

Eltrombopag in Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Assiut University 20
Post-approval studies (Phase 4)Looking for participantsNCT04518475
What this trial is testing

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 224
Not applicableStudy completedNCT01236014
What this trial is testing

Indirect Comparison Between Eltrombopag & Romiplostim

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 1
Not applicableStudy completedNCT06458803
What this trial is testing

Efficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue Disease

Who this might be right for
Refractory ThrombocytopeniaConnective Tissue Diseases
Tongji Hospital 52
Early research (Phase 1)Study completedNCT00688272
What this trial is testing

Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 36
Testing effectiveness (Phase 2)Looking for participantsNCT04304820
What this trial is testing

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Who this might be right for
Severe Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 80
Early research (Phase 1)Study completedNCT01072162
What this trial is testing

Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 40
Testing effectiveness (Phase 2)Looking for participantsNCT05961410
What this trial is testing

Eltrombopag for Peripheral Blood Stem Cell Harvest

Who this might be right for
LymphomaPeripheral Blood Stem Cell Transplantation
National Taiwan University Hospital 46
Testing effectiveness (Phase 2)Ended earlyNCT02928419
What this trial is testing

Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q

Who this might be right for
Myelodysplastic Syndromes
Associazione Qol-one 2
Testing effectiveness (Phase 2)Study completedNCT00902018
What this trial is testing

Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 20
Large-scale testing (Phase 3)Study completedNCT00351468
What this trial is testing

EXTEND (Eltrombopag Extended Dosing Study)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
Novartis Pharmaceuticals 302
Testing effectiveness (Phase 2)Study completedNCT01636778
What this trial is testing

Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07558434
What this trial is testing

CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

Who this might be right for
Severe Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia
Peking Union Medical College Hospital 43
Testing effectiveness (Phase 2)Ended earlyNCT01397149
What this trial is testing

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Who this might be right for
Chronic Lymphocytic LeukemiaThrombocytopenia
University of Ulm 4
Testing effectiveness (Phase 2)Study completedNCT06045052
What this trial is testing

Eltrombopag for Treatment of Fanconi Anemia

Who this might be right for
Fanconi Anemia
Julian Sevilla 8
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation